Aethlon Medical Announces Live Webcast Event.

Business Editors and Health/Medical Writers

SAN DIEGO--(BW HealthWire)--March 30, 2001

Aethlon Medical Inc. (OTCBB:AEMD) Friday announced that it will broadcast a live Webcast presentation over the Internet to discuss the development status of the company's HIV-Hemopurifer technology, and to review the current environment and opportunities for treating HIV-infected adults and adolescents.

The event will be broadcast on Wednesday, April 4, 2001 at 1:30 p.m. Pacific/4:30 p.m. Eastern time.

This event is available through the Aethlon Medical Web site, located at http://www.AethlonMedical.com, as well as from the Web site of ViaVid Broadcasting, located at http://www.viavid.com. Viewers should go to either of the Web sites at least 15 minutes before this event to download, and install any necessary audio software. For those unable to attend the live broadcast, a replay will be available shortly after the event. There is no charge to access this event. The event is also available by phone through the following dial-in number(s): North America toll-free 877/888-4210 or for those abroad 416/695-5261. Call in advance to register.

About Aethlon Medical

Aethlon Medical is a development-stage, therapeutic device company engaged in the discovery and development of novel products that rapidly reduce the presence of viruses and other intoxicants in the blood. Aethlons' lead product candidate, the HIV-Hemopurifier(TM) is designed to fill the urgent need for new HIV/AIDS treatments that are effective in reducing viral load, have fewer side effects, and decrease the likelihood of treatment resistance. Recent pre-clinical studies of the HIV-Hemopurifier have documented the removal of 90% of HIV from human blood plasma during the equivalent of an overnight treatment. Other products in the Aethlon technology portfolio include Hemopurifiers that treat lead poisoning, iron overload, and curb the side effects of certain chemotherapy.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical Inc. (the "company"), or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers of this press release may obtain additional information on the company in reports and other information filed in accordance with the Securities Exchange Act of 1934, as amended (the "exchange act"). Such reports and other information filed by the company can be inspected and copied at the public reference facilities maintained by the Commission at the Public Reference Room, 450 Fifth Street, N.W., Washington, D.C. 20549. Copies of such material can also be obtained at prescribed rates from the Public Reference Section of the Commission, Washington, D.C. 20549 or by calling the Commission at 800/SEC-0330. In addition, Registration Statements

and other filings made with the Commission through its Electronic Data Gathering Analysis and Retrieval System ("EDGAR") and publicly available through the Commission's Web site located at http://www.sec.gov.